Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Adenosine mechanism

Treatment of adenosine with nitrous acid gives a nucleoside known as mosine Suggest a reasonable mechanism for this reaction... [Pg.1190]

Contraction of muscle follows an increase of Ca " in the muscle cell as a result of nerve stimulation. This initiates processes which cause the proteins myosin and actin to be drawn together making the cell shorter and thicker. The return of the Ca " to its storage site, the sarcoplasmic reticulum, by an active pump mechanism allows the contracted muscle to relax (27). Calcium ion, also a factor in the release of acetylcholine on stimulation of nerve cells, influences the permeabiUty of cell membranes activates enzymes, such as adenosine triphosphatase (ATPase), Hpase, and some proteolytic enzymes and facihtates intestinal absorption of vitamin B 2 [68-19-9] (28). [Pg.376]

Factors controlling calcium homeostasis are calcitonin, parathyroid hormone(PTH), and a vitamin D metabolite. Calcitonin, a polypeptide of 32 amino acid residues, mol wt - SGOO, is synthesized by the thyroid gland. Release is stimulated by small increases in blood Ca " concentration. The sites of action of calcitonin are the bones and kidneys. Calcitonin increases bone calcification, thereby inhibiting resorption. In the kidney, it inhibits Ca " reabsorption and increases Ca " excretion in urine. Calcitonin operates via a cyclic adenosine monophosphate (cAMP) mechanism. [Pg.376]

Pig. 2. Proposed mechanism of inbition of smooth muscle contraction by P2" gonists, where AMP is adenosine monophosphate, cAMP is cycHc-3 5 adenosine monophosphate, ATP is adenosine triphosphate, and -P is an attached phosphate. [Pg.438]

Dismption of the endothehal surface of blood vessels expose coUagen fibers and connective tissue. These provide surfaces that promote platelet adherence, platelet release reaction, and subsequent platelet aggregation. Substances Hberated from the platelets stimulate further platelet aggregation, eg, adenosine diphosphate maintain vasoconstriction, eg, serotonin and participate in blood coagulation, eg, platelet Factors III and IV. In addition, the release reaction modifies platelet membranes in a manner that renders phosphoHpid available for coagulation. The thrombin [9002-04-4] elaborated by the coagulation mechanism is a potent agent in the induction of the platelet release reaction. [Pg.171]

In the presence of calcium, the primary contractile protein, myosin, is phosphorylated by the myosin light-chain kinase initiating the subsequent actin-activation of the myosin adenosine triphosphate activity and resulting in muscle contraction. Removal of calcium inactivates the kinase and allows the myosin light chain to dephosphorylate myosin which results in muscle relaxation. Therefore the general biochemical mechanism for the muscle contractile process is dependent on the avaUabUity of a sufficient intraceUular calcium concentration. [Pg.125]

Phosphodiesterase Inhibitors. Because of the complexity of the biochemical processes involved in cardiac muscle contraction, investigators have looked at these pathways for other means of dmg intervention for CHF. One of the areas of investigation involves increased cycHc adenosine monophosphate [60-92-4] (cAMP) through inhibition of phosphodiesterase [9025-82-5] (PDE). This class of compounds includes amrinone, considered beneficial for CHF because of positive inotropic and vasodilator activity. The mechanism of inotropic action involves the inhibition of PDE, which in turn inhibits the intracellular hydrolysis of cAMP (130). In cascade fashion, cAMP-catalyzed phosphorylation of sarcolemmal calcium-channels follows, activating the calcium pump (131). A series of synthetic moieties including the bipyridines, amrinone and milrinone, piroximone and enoximone, [77671-31-9], C22H22N2O2S, all of which have been shown to improve cardiac contractiUty in short-term studies, were developed (132,133). These dmgs... [Pg.129]

Lymn, R.W. Taylor, E.W. Mechanism of adenosine triphosphate hydrolysis of actomyosin. Biochemistry 10 4617-4624, 1971. [Pg.298]

Further computational studies on adenines and adenosines concern the reaction mechanism of ribonuclease A with cytidyl-3,5 -adenosine [99BP697] and the molecular recognition of modified adenine nucleotides [99JMC5338]. [Pg.65]

RNA-editing is a posttranscriptional mechanism mediated by RNA editases, which results in a site-selective deamination of adenosine to inosine. This alters codons and splicing in nuclear transcripts and thereby alters the structure and function of proteins. [Pg.1090]

Caffeine binds to adenosine receptors in the brain, preventing adenosine from inducing sleep or opening blood vessels. Caffeine also increases levels of dopamine, the neurotransmitter associated with pleasure. This is the chemical mechanism for addiction. The response to adenosine competition causes increased adrenaline flow. [Pg.158]

Stein, L.A., Schwarz, R., Chock, P.B., Eisenberg, E. (1979). Mechanism of actomyosin adenosine triphosphatase. Evidence that adenosine 5 -triphosphate hydrolysis can occur without dissociation of the actomyosin complex. Biochemistry 18, 3895-3909. [Pg.237]

The biosynthesis of purines and pyrimidines is stringently regulated and coordinated by feedback mechanisms that ensure their production in quantities and at times appropriate to varying physiologic demand. Genetic diseases of purine metabolism include gout, Lesch-Nyhan syndrome, adenosine deaminase deficiency, and purine nucleoside phosphorylase deficiency. By contrast, apart from the orotic acidurias, there are few clinically significant disorders of pyrimidine catabolism. [Pg.293]

Ferre, S, Fredholm, BB, Morelli, M, Popoli, P and Fuxe, K (1997) Adenosine-dopamine receptor-receptor interaction as an integrative mechanism in the basal ganglia. Trends Neurosci. 20 482-487. [Pg.323]

There are important inhibitory systems built into the control of events following C-fibre stimulation. Thus, during peripheral noxious stimulation, spinal mechanism, driven by NMDA-receptor-mediated activity, can become active to damp down further neuronal responses, the purine, adenosine (see Chapter 13), appears to be involved in this type of control and has been reported to be effective in humans with neuropathic pain. It is thought that the depolarisations caused by activation of the NMDA receptor increase the metabolic demand on neurons and so ATP utilisation increases. ATP then is metabolised to adenosene and the purine then acts on its inhibitory Ai receptor in the... [Pg.465]


See other pages where Adenosine mechanism is mentioned: [Pg.325]    [Pg.24]    [Pg.325]    [Pg.24]    [Pg.713]    [Pg.2828]    [Pg.2828]    [Pg.534]    [Pg.95]    [Pg.536]    [Pg.441]    [Pg.211]    [Pg.497]    [Pg.110]    [Pg.127]    [Pg.445]    [Pg.358]    [Pg.658]    [Pg.693]    [Pg.20]    [Pg.20]    [Pg.20]    [Pg.119]    [Pg.266]    [Pg.287]    [Pg.358]    [Pg.191]    [Pg.10]    [Pg.83]    [Pg.34]    [Pg.309]    [Pg.38]    [Pg.132]    [Pg.177]   
See also in sourсe #XX -- [ Pg.38 , Pg.153 ]




SEARCH



Adenosine 5 -triphosphate mechanism

Adenosine aminohydrolase mechanism

Adenosine deaminase deficiency mechanism

Adenosine triphosphate synthetase mechanisms

Phosphorylation, adenosine mechanism

© 2024 chempedia.info